Major Grants to Support Human Clinical Trials Advance Research Into Uses of Stem Cells From Cord and Placenta Tissue

Posted: Published on November 28th, 2012

This post was added by Dr. Richardson

Americord Registry Offers Exclusive Service Preserving Stem Cells From Cord Tissue and Placenta Tissue

New York, NY (PRWEB) November 26, 2012

MSCs, which can easily be harvested from umbilical cord tissue and placenta tissue when a baby is born, are in fact currently the subject of over 200 clinical trials. While MSCs are not yet being used for medical therapies, research has indicated that they hold the promise of being able to someday treat debilitating conditions such as heart disease, type 1 diabetes, lung cancer, Parkinsons Disease, and injuries to bones and cartilage.

Americord Registry offers the ability to preserve MSCs. We are committed to helping parents-to-be expand their babys options for future medical treatment, said Americord CEO Martin Smithmyer. Offering the option to preserve MSCs from umbilical cord tissue and placenta tissue is just one of the ways that we are pioneering best-in-class services in the cord blood industry. We are also working closely with scientists to develop a proprietary product that will significant increase the volume of stem cells that can be preserved when a baby is born.

Americord Registry also offers the ability to preserve stem cells from umbilical cord blood. Parents-to-be can preserve stem cells from just umbilical cord blood, from cord blood and cord tissue, or from cord blood, cord tissue and placenta tissue. For a comparison of Americords prices and services with other leading cord blood companies, visit Americords website.

About Americord Registry

Americord Registry is a leader in the advancement of umbilical cord blood, cord tissue and placenta tissue banking. Americord collects, processes, and stores newborn stem cells from umbilical cord blood for future medical or therapeutic use, including the treatment of more than 80 blood diseases such as sickle cell anemia and leukemia. Founded in 2008, Americord is registered with the FDA and operates in all 50 states. The company's laboratory is CLIA Certified, accredited by the AABB and complies with all federal and state guidelines and applicable licenses. Americord is headquartered in New York, NY. You may visit Americord Registry's website at http://www.cordadvantage.com for more information. You may also find Americord Registry on Facebook and follow the company on Twitter.

###

Andrew Flook Americord Registry 866-503-6005 Email Information

Continue reading here:
Major Grants to Support Human Clinical Trials Advance Research Into Uses of Stem Cells From Cord and Placenta Tissue

Related Posts
This entry was posted in Mesenchymal Stem Cells. Bookmark the permalink.

Comments are closed.